Elevation of Thymidylate Synthase following 5-Fluorouracil Treatment Is Prevented by the Addition of Leucovorin in Murine Colon Tumors

Cancer Research

Volumn 52, Issue 18, 1992, Pages 4922-4928

  Van der Wilt, Clasina L ^a   Pinedo, Herbert M ^a   Smid, Kees ^a   Peters, Godefridus J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE PHOSPHATE; FLUOROURACIL; FOLINIC ACID; TETRAHYDROFOLIC ACID; THYMIDYLATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON TUMOR; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ASSAY; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; COLONIC NEOPLASMS; DRUG SYNERGISM; FLUOROURACIL; LEUCOVORIN; MICE; SUPPORT, NON-U.S. GOV'T; THYMIDYLATE SYNTHASE; TIME FACTORS;

EID: 0026788343     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Pinedo, H. M., and Peters, G. J. 5-Fluorouracil: biochemistry and pharmacology. J. Clin. Oncol., 6: 1653-1664, 1988.
2. Lockshin, A., and Danenberg, P. V. Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthase. Biochem. Pharmacol., 30: 247-257, 1981.
3. Houghton, J., Schmidt, C., and Houghton, P. J. The effect of derivatives of folic acid on the fluorodeoxyuridylate thymidylate synthetase covalent complex in human colon xenogts. Eur. J. Cancer Clin. Oncol., 18: 347-354, 1982.
4. Cisneros, R., and Dunlap, R. B. Characterization of the parameters affecting covalent binding stoichiometry in binary and ternary complexes of thymidylate synthase. Biochim. Biophys. Acta, 1039:149-156, 1990.
5. Keyomarsi, K., and Moran, R. G. Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells. J. Biol. Chem., 263: 14402-14409, 1988.
6. Evans, R. M., Laskin, J. D., and Hakala, M. T. Effect of excess folates and deoxyinosine on the activity and the site of action of fluorouracil. Cancer Res., 41: 3288-3295, 1981.
7. Kane, M. A., Roth, E., Raptis, G., Schreiber, C., and Waxman, S. Effect of intracellular folate concentration on the modulation of 5-f1uorouracil cytotoxicity by the elevation of phosphoribosylpyrophosphate in cultured human KB ceUs. Cancer Res., 47:6444-6450, 1987.
8. Wright, J. E., Dreyfuss, A., El-Magharbel, I., Trites, D., Jones, S. M., Holden, S. A., Rosowsky, A., and Frei, E., III. Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo. Cancer Res., 49: 2592-2596, 1989.
9. Nadal, J. C., Van Groeningen, C. J., Pinedo, H. M., and Peters, G. J. In vivo potentiation of 5-f1uorouracil by leucovorin in murine colon carcinoma. Biomed. Pharmacother., 42: 387-393, 1988.
10. Nadal, J. C., Van Groeningen, C. J., Pinedo, H. M., and Peters, G. J. Schedule-dependency of in vivo modulation of 5-f1uorouracil by leucovorin and uridine in murine colon carcinoma. Invest. New Drugs, 7: 163-172, 1989.
11. Arbuck, S. Overview: clinical trials using 5-f1uorouracil and leucovorin for the treatment of colorectal cancer. Cancer (Phila.), 63 (Suppl.); 1036-1044, 1989.
12. Petrelli, N., Douglas, H. O., Jr., Herrera, L., Rusell, D., Stablein, D. M., Bruckner, H. W., Schinella, R., Green, M. D., Muggia, F. M., Megibow, A., Greenwald, E. S., Levin, B., Gaynor, E., Loutfi, A., Kaiser, M. H., Barkin, J. S., Benedatta, P., Woolley, P. V., Nauta, R., Weaver, D. W., and Leichman, L. P. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J. Qin. Oncol., 7:1419-1426, 1989.
13. Fernandes, D. J., and Cranford, S. K. A method for the determination of total, free, and 5-fluorodeoxyuridylate-bound thymidylate synthase in cell extracts. Anal. Biochem., 142: 378-385, 1984.
14. Moran, R. G., Spears, C. P., and Heidelberger, C. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate and thymidylate synthetase. Proc. Natl. Acad. Sci. USA, 76:1456-1460, 1979.
15. Spears, C. P., Shahinian, A. H., Moran, R. G., Heidelberger, C., and Corbett, T. H. In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res., 42: 450-456, 1982.
16. Houghton, J. A., Radparvar, S., Torrance, P. M., Williams, L., and Houghton, P. J. Determination of thymidylate synthase activity in colon tumor tissue after treatment with 5-fluorouracil. Biochem. Pharmacol., 36: 1285-1289, 1987.
17. Berne, M. H. O., GusUvsson, B. G., Almersjd, O., Spears, C. P., and Frosing, R. Sequential methotrexate/5FU: FdUMP formation and TS inhibition in a transplanuble rodent colon adenocarcinoma. Cancer Chemother. Pharmacol., 16: 237-242, 1986.
18. Spears, C. P., Gustavsson, B. G., Mitchell, M. S., Spicer, D., Berne, M., Bernstein, L., and Danenberg, P. V. Thymidylate synthase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res., 44:4144-4150, 1984.
19. Spears, C. P., Gustavsson, B. G., Bcrnc, M., Frosing, R., Berastein, L., and Hayes, A. A. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-Fluorouracil. Cancer Res., 48:5894-5900, 1988.
20. Peters, G. J., Van Groeningen, C. J., Laurensse, E., Van der Wilt, C. L., Meuer, S., and Pinedo, H. M. Evaluation of in vivo inhibition of thymidylate syntase in patients with colorectal cancer treated with 5-fluorouracil. In: H-C. Curtis, S. Ghisla, and N. Blau (eds.). Chemistry and Biology of Pteridines, pp. 848-851. New York: Walter de Gruyter, 1990.
21. Peters, G. J., Van Groeningen, C. J., Van der WUt, C. L., Meger, S., Smid, K., Laurensse, E., and Pinedo, H. M. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin. Semin. Oncol., 19 (Suppl. 3); 26-35, 1992.
22. Trave, F., Rustum, Y. M., Petrelli, N. J., Herrera, L., Mittelman, A., Frank, C., and Creaven, P. J. Plajma and tumor tissue pharmacology of high-dose intravenous leucovorin in combination with fluorouracil in patients with advanced colorectal carcinoma. J. Clin. Oncol., 6:1184-1191,1988.
23. Peters, G. J., Braakhuis, B. J. M., de Bruyn, E. A., Laurensse, E., Van Walsum, M., and Pinedo, H. M. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolizing enzymes. Br. J. Cancer, 59: 327-334, 1989.
24. Peters, G. J., Van der WUt, C. L., Smid, K., Ruiz van Haperen, V., Veerman, G., Laurensse, E., and Pinedo, H. M. P)iimidine metabolism in murine colon cancer models: relevance for chemotherapy with antimetabolites. Biochem. Pharmacol. (Life Sci. Adv.), 9: 365-373, 1990.
25. Peters, G. J., Van Dijk, J., Laurensse, E., Van Groeningen, C. J., Leyva, A., Nadal, J. C., and Pinedo, H. M. In vitro biochemical and in vivo Biological studies of uridine “rescue” of 5-fluorouracil. Br. J. Cancer, 57: 259-265, 1988.
26. Creaven, P. J., Petrelli, N., Rustum, Y. M., Herrerra, L., Cowens, J. W., Arbuck, S. G., George, M., Letvak, L., and Proefnxrk, A. Phase 1 study of 65-leucovorin and 5-fluorouracil in colorectal carcinoma. Proc. Am. Assoc. Cancer Res., 32: 174, 1991.
27. Rustum, Y. M., Zhang, Z-G., Frank, C., Creaven, P. J., and Petrelli, N. Pharmacokinetics of the Biologically active isomer, 65-leucovorin, in patients with advanced colorectal cancer. Proc. Am. Assoc. Cancer Res., 32: 174, 1991.
28. Peters, G. J., Laurensse, E., Leyva, A., Lankelma, J., and Pinedo, H. M. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res., 46: 20-28, 1986.
29. Peters, G. J., Laurensse, E., Leyva, A., and Pinedo, H. M. Tissue homogenization using a microdismembrator for the measurement of enzyme activities. Clin. Chim. Acta, 158: 193-198, 1986.
30. Bradford, M. A rapid and sensitive method for the quantiution of microgram quantaties of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
31. Peters, G. J., Van Groeningen, C. J., Laurensse, E. J., and Pinedo, H. M. Thymidylate synthase from untreated human colorectal and colonic mucosa: enzyme activity and inhibition by 5-fluoro-2'-deoxyuridine-monophosphate. Eur. J. Cancer, 27: 263-267, 1991.
32. Peters, G. J., Kraal, I., Laurensse, E., Leyva, A., and Pinedo, H. M. Separation of 5-fluorouracil and uracil by ion-pair reversed-phase high-performance liquid chromatography on a column with porous polymeric packing. J. Chromatogr., 307:464-468, 1984.
33. Van der Wilt, C. L., Pinedo, H. M., Smid, K., Cloos, J., Noordhuis, P., and Peters, G. J. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase. Semin. Oncol., 19 (Suppl. 3); 16-25, 1992.
34. Visser, G. M. W., Gorree, G. C. M., Peters, G. J., and Herscheid, J. D. M. Tissue distribution of [18F]-fluorouracil in mice: effects of route of administration, strain, tumour and dose. Cancer Chemother. Pharmacol., 26:205-209, 1990.
35. Peters, G. J., Laurensse, E., Leyva, A., and Pinedo, H. M. Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity. Eur. J. Cancer Clin. Oncol., 23: 1869-1881, 1987.
36. Mini, E., Trave, F., Rustum, Y. M., and Bertino, J. R. Enhancement of the antitumor effects of 5-fluorouracil by folinic acid. Pharmacol. Ther., 47: 1-19, 1990.
37. Davis, S. T., and Berger, S. H. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase. Mol. Pharmacol., 35:422-427, 1989.
38. Berger, S. H., Barbour, K. W., and Berger, F. A naturally occuring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line. Mol. Pharmacol., 480-484, 1988.
39. Mullin, R. J., Keith, B. R., and Duch, D. S. Distribution and metobolism of calcium leucovorin in normal and tumor tissue. Adv. Exp. Med. Biol., 244: 25-38, 1988.
40. Houghton, J. A., Williams, L. G., de Graaf, S. S. N., Cheshire, P. J., Rodman, J. H., Maneval, D. C., Wainer, I. W., Jadaud, P., and Houghton, P. J. Relationship between dose rate of (6l2S)-leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts. Cancer Res., 50: 3493-3502, 1990.
41. Lonn, U., and Lonn, S. Increased levels of DNA lesions induced by leucovorin-fluoropyrimidine in human colon adenocarcinoma. Cancer Res., 48: 4153-4157, 1988.
42. Damowski, J. W., SaWyer, R. L., Martin, D. S., and Lau-Cam, C. A. Decreased host toxicity in vivo during chronic treatment with 5-fluorouracil. Cancer Chemother. Pharmacol., 14:63-69, 1985.
43. Washtien, W. L. Increased levels of thymidyiate synthase in cells exposed to 5-fluorouracU. Mol. Pharmacol., 25: 171-177, 1984.
44. Chu, E., Zinn, S., Boarman, D., and Allegra, C. J. Interaction of y interferon and 5-fluorouracU in the H630 human colon carcinoma cell line. Cancer Res., 50: 5834-5840, 1990.
45. Swain, S. M., Lippmim, M. E., Egan, E. F., Drake, J. C., Steinberg, S. M., and Allegra, C. J. Ruorouracil and high dose leucovorin in previously treated patients with metasutic breast cancer. J. Clin. Oncol., 7: 890-899, 1989.
46. Cadman, E., and Heimer, R. Levels of thymidyiate synthase during normal growth of L1210 cells. Cancer Res., 46:1195-1198, 1986.
47. Jenh, C. H., Geyer, P. K., Baskin, F., and Johnson, L. F. Thymidyiate synthase gene amplification in fluorodeoxyuridine-resistant mouse cell lines. Mol. Pharmacol., 28: 80-85, 1985.
48. Davis, S. T., and Berger, S. H. Genetic variation in thymidyiate synthase structure is associated with 5-fluoropyrimidine resistance in human colonic tumor cells. Proc. Am. Assoc. Cancer Res., 31:422, 1990.
49. Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Volkenandt, M., Shea, L. C. C., Aigner, K., Gustavsson, B., Leichman, L., Frosing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidyiate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52:108-116, 1992.
50. Dohiick, B. J., Zhang, Z-G., and Rustum, Y. Quantitative polymerase chain reaction assays for human thymidyiate synthase and dihydrofolate reductase mRNA. Proc. Am. Assoc. Cancer Res., 32:327, 1991.